Understanding how genes affect breast cancer risk
Official title: The Rutgers University Genetics Coordinating Center Breast Cancer Study
Run by Rutgers, The State University of New Jersey · NCT06773897 · Data updated 2026-11-12
This study is trying to see how genes affect the risk of breast cancer by collecting health surveys and saliva samples from people aged 18 and older in the US.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25000 (estimated) |
| Sponsor | Rutgers, The State University of New Jersey Academic / other |
| Locations | 1 site (Piscataway, New Jersey) |
| Status | Recruiting |
| Started | April 15, 2024 |
| Main results expected | April 15, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT06773897 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older living in the US who are interested in contributing to breast cancer research.
✕Probably not a fit
Patients who do not meet the inclusion criteria or are not interested in genetic research may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the genetic factors influencing breast cancer risk by collecting health surveys and saliva samples from participants. Individuals aged 18 and older living in the US can participate online, with no prior cancer diagnosis required. The study seeks to enhance knowledge about the genetic basis of breast cancer, which is essential for future drug development. Participants may also receive complimentary information about their genetic ancestry. The study emphasizes diversity among participants, including men, to maximize data utility.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding of breast cancer genetics, potentially informing better prevention and treatment strategies.
How similar studies have gone: Other studies focusing on genetic factors in breast cancer have shown promise, indicating that this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18 years or older * currently living in the United States * able to understand and follow written instructions in English * have access to the internet and a computer, laptop, tablet or smart phone * willing to provide written informed consent for participation * willing to provide DNA via a saliva sample using a collection kit mailed to the study participant's home * willing to complete a survey with questions about health related to the study of breast cancer. Exclusion Criteria: * Not able to meet or fulfill any of the inclusion criteria
Where it's running
-
Rutgers University
Piscataway, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Tara Matise, Ph.D. — Rutgers, The State University of New Jersey
- Study coordinator: Tara Matise, Ph.D.
- Email: rugcc@rutgers.edu
- Phone: 848-445-3125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetic assessment of breast cancer risk for women in the DORA programme
This study tests whether a detailed clinical and genetic review can better classify breast cancer risk for women previously identified as moderately increased or high risk.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.